1. Home
  2. ZLAB vs IFS Comparison

ZLAB vs IFS Comparison

Compare ZLAB & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • IFS
  • Stock Information
  • Founded
  • ZLAB 2013
  • IFS 1897
  • Country
  • ZLAB China
  • IFS Peru
  • Employees
  • ZLAB N/A
  • IFS N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • IFS Commercial Banks
  • Sector
  • ZLAB Health Care
  • IFS Finance
  • Exchange
  • ZLAB Nasdaq
  • IFS Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • IFS 4.2B
  • IPO Year
  • ZLAB 2017
  • IFS 2019
  • Fundamental
  • Price
  • ZLAB $33.34
  • IFS $40.10
  • Analyst Decision
  • ZLAB Buy
  • IFS Buy
  • Analyst Count
  • ZLAB 6
  • IFS 1
  • Target Price
  • ZLAB $57.22
  • IFS $30.00
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • IFS 210.5K
  • Earning Date
  • ZLAB 08-07-2025
  • IFS 08-11-2025
  • Dividend Yield
  • ZLAB N/A
  • IFS 2.37%
  • EPS Growth
  • ZLAB N/A
  • IFS 112.04
  • EPS
  • ZLAB N/A
  • IFS 4.72
  • Revenue
  • ZLAB $427,799,000.00
  • IFS $1,492,951,578.00
  • Revenue This Year
  • ZLAB $42.62
  • IFS N/A
  • Revenue Next Year
  • ZLAB $55.12
  • IFS $10.80
  • P/E Ratio
  • ZLAB N/A
  • IFS $8.48
  • Revenue Growth
  • ZLAB 32.56
  • IFS 34.92
  • 52 Week Low
  • ZLAB $18.91
  • IFS $23.95
  • 52 Week High
  • ZLAB $44.34
  • IFS $40.25
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • IFS 65.37
  • Support Level
  • ZLAB $31.79
  • IFS $38.96
  • Resistance Level
  • ZLAB $35.45
  • IFS $40.06
  • Average True Range (ATR)
  • ZLAB 1.00
  • IFS 0.72
  • MACD
  • ZLAB -0.22
  • IFS 0.10
  • Stochastic Oscillator
  • ZLAB 31.12
  • IFS 93.32

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.

Share on Social Networks: